2024: Technology Breakthrough Period (High-end Customization + Global Layout)
1. Strategic Cooperation Achievements
Signed a Supply Agreement for High-end Peptide Intermediates with Pfizer Inc. (USA): Provided Fmoc-protected amino acids and peptide coupling intermediates for Pfizer's oncology drug production, with an annual supply volume of 1,500 tons and a contract value of 42 million US dollars. Becoming Pfizer's sole Asian supplier for this high-value category, the company's products meet USP Class 1 standards with peptide purity ≥ 99.9% and water content .2%, breaking the European and American monopoly.
Co-built a Pharmaceutical Intermediate R&D & Production Base in Singapore: Jointly invested 250 million US dollars with Singapore's Temasek Holdings to construct a 15,000-ton/year custom synthesis plant. Focusing on advanced intermediates for biologics and specialty drugs, the base will provide one-stop customization services for global pharmaceutical companies, with an expected annual sales volume exceeding 280 million US dollars after commissioning.
2. Export Scale Cases
Explosive Growth in Special Heterocyclic Intermediates Exports: Exported imidazole, pyrimidine and triazine derivatives to the EU, the Middle East and Japan, with an annual export volume of 10,000 tons and an export value of 280 million RMB, a year-on-year increase of 58%. The products meet ICH Q7 guidelines, accounting for 9% of Germany's specialty pharmaceutical intermediate market.
Full-scale Expansion in Latin American and Caribbean Markets: Exported beta-lactam intermediates and steroid intermediates to Brazil, Mexico, Cuba and other countries, with an annual export volume of 15,000 tons and an export value of 190 million RMB, a year-on-year growth of 68%. Among them, the market share in Brazil's API intermediate sector increased to 13%.
3. Market Breakthrough Cases
Breakthrough in North American Biopharmaceutical Intermediates: PEGylated intermediates (polyethylene glycol derivatives) obtained U.S. FDA DMF (Drug Master File) registration, entering the U.S. biologic drug production market with an annual export volume of 700 tons. The company became the only mainland Chinese supplier accessing North America's high-end biopharmaceutical intermediate market.
Upgraded Localized Technical Services in Europe: Established a technical support center in Frankfurt, Germany, providing process optimization, impurity control and regulatory compliance solutions for European pharmaceutical companies. This drove annual sales in the region to 85 million RMB with a customer repurchase rate of 94%.
Comprehensive Warehouse Solutions
With a broad level of expertise, Crown can serve as the single point of contact for your warehouse project.
Warehouse Design Services
Expert space-planning consultation for your specific needs
Racking & Storage Solutions
A broad selection of products for a customized storage system
Warehouse Products
All the products you need to complete your warehouse set up
Contact Us
Contact Us Let's TalkYour Any Query
Subscribe For Newsletter!
Your Email...
